Peripartum Management for Patients Receiving Medication for Opioid Use Disorder.

Henry Paiste¹, Brendan Lynch², Grace Lim³

¹Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, UPMC Magee Women's Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA. Electronic address: paistehj@upmc.edu.

²Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, UPMC Magee Women's Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA.

³Department of Anesthesiology, Perioperative and Pain Medicine, University of Utah, HELIX Building 505030 North Mario Capecchi Drive, Salt Lake City, UT 84112, USA.

PubMed DOI

Abstract

This review discusses the rising impact of opioid use disorder (OUD) on peripartum care, highlighting the maternal and neonatal risks, including neonatal abstinence syndrome. It traces the US opioid crisis from aggressive 1990s prescribing to 2016 Center for Disease Control guidelines and notes enduring regional disparities in opioid prescriptions. The text distinguishes OUD from opioid-induced hy…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.